Compound Detail
CHEMBL1439
TAZOBACTAM SODIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
7
Targets
25
Activities
1
Assay Types
0
PK Parameters
20
Publications
9
Known Names
11
Indications
1
Mechanisms
Molecular Properties
300.3
MW (Da)
-1.52
ALogP
7
HBA
1
HBD
122.5
PSA (Ų)
0.67
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1993 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Bacterial beta-lactamase TEM inhibitor | INHIBITOR | Beta-lactamase TEM | ✓ | ✓ |
Indications
Appendicitis Cellulitis Diabetic Foot Endometritis Healthcare-Associated Pneumonia Intraabdominal Infections Pelvic Inflammatory Disease Peritonitis Pneumonia Urinary Tract Infections Infections
Activity Summary
IC50 25 meas. best 7.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-lactamase TEM CHEMBL2065 | IC50 | 7.6 | 7.19 | 25.0 | 5 |
| Unchecked CHEMBL612545 | IC50 | 7.0 | 5.54 | 100.0 | 2 |
| Beta-lactamase CHEMBL4114 | IC50 | 6.54 | 5.6817 | 290.0 | 6 |
| Beta-lactamase TEM CHEMBL3652 | IC50 | 6.5 | 6.5 | 320.0 | 1 |
| Beta-lactamase CHEMBL2725 | IC50 | 6.03 | 5.17 | 943.0 | 3 |
| Beta-lactamase CHEMBL2026 | IC50 | 6.02 | 4.7325 | 950.0 | 4 |
| Beta-lactamase class C CHEMBL3499 | IC50 | 5.47 | 4.6867 | 3400.0 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine